 |
Jekk jogħġbok innota li din il-websajt se tkun qed tgħaddi minn xi aġġornamenti din il-ġimgħa. Konsegwentement, l-utenti jistgħu jesperjenzaw instabilità u funzjonalità limitata. Niskużaw ruħna għall-inkonvenjenza.. ("Google tradotta" mill Ingliż oriġinali) |
For a better user experience please update your browser or use Chrome or Firefox browser.
Utilitajiet
Publication detail
Home
Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 July 2004 to 15 August 2004 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 July 2004 to 15 August 2004 (Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93)
Metadejta tal-pubblikazzjoni
- Ippubblikat:
- Awtur(i) korporattiv(i): Il-Kummissjoni Ewropea
- Suġġett: approvazzjoni ta' bejgħ , kummerċjalizzazzjoni , prodott mediċinali
- CELEX : 52004XC0827(02)
- OJ : JOC_2004_215_R_0007_01
Viżwalizzatur tad-dokument
Note:
Il-pubblikazzjoni ma tistax tintwera fil-viżwalizzatur tad-dokument. Verżjoni miftuħa fuq l-internet
Tista’ taċċessaha minn: Iddawnlowdjar u lingwi